Application 761382

Type
BLA
Sponsor
SANDOZ INC

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761382Enzeevuaflibercept-abzv351(k) InterchangeableRx2026-10-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ENZEEVUAFLIBERCEPT-ABZVINJECTABLE;INJECTION2MG(0.05ML of 40MG/ML)NoNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ENZEEVUAFLIBERCEPTSandoz Inc6f1d28a8-1c10-40d2-83f0-6a528f807b922026-04-24Warnings, Adverse reactionsExact identifier
application number: BLA761382

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85067SUPPL 2026-02-18
85038SUPPL 2026-02-12
81216SUPPL 2025-02-11
81208SUPPL 2025-02-11
79377ORIG 2024-08-12
79362ORIG 2024-08-12